LINC01242

Across TCGA pan-cancer cohorts, LINC01242 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated LINC01242 data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher LINC01242 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01242 expression acts as an unfavorable survival marker, although some lineages such as LUSC and SKCM show a favorable association.

PAAD, BLCA, and READ are the cancer types where LINC01242 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	DFS	Tertile	II,III,IV	0.095	0.474	.004	36	view →
BLCA	DFS	Tertile	IV	0.131	0.488	.003	36	view →
READ	DFS	Tertile	All	0.336	0.843	.023	36	view →
LIHC	DFS	Tertile	All	0.344	0.469	.002	21	view →
LUSC	DFS	Tertile	III,IV	0.802	0.276	.024	18	view →
COAD	DFS	Tertile	III,IV	0.175	0.623	.007	18	view →
SKCM	OS	Tertile	III,IV	1.000	0.353	.012	12	view →
KICH	OS	Tertile	All	0.648	0.972	.012	9	view →
STAD	DFS	Tertile	IV	0.160	0.402	.044	9	view →
THCA	DFS	Tertile	All	0.835	0.950	.019	6	view →
SARC	OS	Tertile	All	0.681	0.878	.022	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

LINC01242–PAAD (DFS)

Open the PAAD breakdown →